20816-79-9Relevant articles and documents
-
Bergmann,Hirshberg
, p. 331,334 (1936)
-
COVALENT RAS INHIBITORS AND USES THEREOF
-
, (2021/06/04)
The disclosure features compounds, or pharmaceutically acceptable salts thereof, alone and in combination with other therapeutic agents, pharmaceutical compositions, and protein conjugates thereof, capable of modulating biological processes including Ras, and their uses in the treatment of cancers.
KRAS G12C INHIBITORS
-
, (2020/07/25)
The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.